30 Day

Goop DTF Supplement for Women’s Libido & Well-being

STUDY TITLE Goop DTF Supplement for Women’s Libido & Well-being
Submitted under umbrella

Minimal Risk Citizen Science Umbrella Protocol

Date submitted

-

End date

There is no pre-specified end date and sub-studies remain open long-term.

Language

English

Efforia AI IRB approval recommendation

Recruitment page preview

Preview

Author edit

Edit

Informed consent

Review

Study author

Matthew Amsden

Principal investigator

Matthew Amsden

Sub-Investigator for Adverse Events

Dr. Viral Patel

Description

This protocol evaluates the effects of the Goop DTF herbal supplement on women's libido, stress, and overall quality of life. Participants will take one capsule every morning for 30 days. The study aims to observe changes in sexual satisfaction, stress, and well-being without introducing other factors that may affect outcomes. Does this change?

Participant engagement length

30 Days

Sponsor

This study is made possible by your payment to cover all supplies and expenses required to participate.

Cost to participant

$0

Included products & services
Outcome measures

PROMIS® Scale v2.0 – Satisfaction With Sex Life Survey

Sexual Desire Inventory-2 (SDI-2) Survey for Men & Women

Depression, Anxiety and Stress Scales (DASS-21) Survey

Methodology

Single Arm longitudinal where participants act as their own control

Basic or advanced dissemination plan

Basic

Deviation from recruitment approach

No

Deviation from statistical approach

No

Will study include “more about you questions”

No

Clinicaltrials.Gov

Yes

Committment to list findings on clinicaltrials.Gov

Yes

This document is prepared with the assistance of AI, but is reviewed by a human.

Rational & Study Design

The Intervention

Included Products & Services

Study Design & Methodology

Inappropriate Participants & Inclusion/Exclusion

Study Design & Experience

Statistical Analysis Plan

Limitations & Justification

Human Subjects Ethics

Suitability Under Minimal Risk Umbrella Protocol

Suitability for Pay to Participate Model

Human Subjects Protection Questionnaire